StockData
Co-Diagnostics, Inc. logo

Co-Diagnostics, Inc. (CODX) stock

CODXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/30
$0.22−0.03 (-13.03%)

Close on Nov 16, 2026Market cap $1.41MP/E –Yield –

Co-Diagnostics gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Co-Diagnostics's gross profit for the twelve months ending Jun 30, 2026 was $313.64K, down 21.1% year over year. For fiscal 2025 it was $400.11K, down 86.3% from the year before. The highest annual figure on record is $86.31M in fiscal 2021.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025$400.11K-86.3%
FY2024Dec 31, 2024$2.92M+11.0%
FY2023Dec 31, 2023$2.63M-90.9%
FY2022Dec 31, 2022$28.74M-66.7%
FY2021Dec 31, 2021$86.31M+48.9%
FY2020Dec 31, 2020$57.96M+56424.0%
FY2019Dec 31, 2019$102.54K+236.0%
FY2018Dec 31, 2018$30.52K+314.7%
FY2017Dec 31, 2017$7.36K–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$120.83K-7.6%
Q1 FY2026Mar 31, 2026-$47.81K-266.7%
Q4 FY2025Dec 31, 2025$121.53K–
Q3 FY2025Sep 30, 2025$119.10K-65.4%
Q2 FY2025Jun 30, 2025$130.80K-94.6%
Q1 FY2025Mar 31, 2025$28.69K-87.7%
Q4 FY2024Dec 31, 2024-$105.74K-118.0%
Q3 FY2024Sep 30, 2024$343.74K-84.4%
Q2 FY2024Jun 30, 2024$2.44M–
Q1 FY2024Mar 31, 2024$233.35K+134.0%
Q4 FY2023Dec 31, 2023$587.34K-33.7%
Q3 FY2023Sep 30, 2023$2.20M-49.1%
Q2 FY2023Jun 30, 2023-$261.29K-106.4%
Q1 FY2023Mar 31, 2023$99.72K-99.5%
Q4 FY2022Dec 31, 2022$885.71K-95.1%
Q3 FY2022Sep 30, 2022$4.33M-83.9%
Q2 FY2022Jun 30, 2022$4.11M-83.5%
Q1 FY2022Mar 31, 2022$19.42M+15.9%
Q4 FY2021Dec 31, 2021$17.91M-21.5%
Q3 FY2021Sep 30, 2021$26.79M+67.5%
Q2 FY2021Jun 30, 2021$24.85M+37.6%
Q1 FY2021Mar 31, 2021$16.75M+1470.3%
Q4 FY2020Dec 31, 2020$22.83M+40846.5%
Q3 FY2020Sep 30, 2020$16.00M+75829.0%
Q2 FY2020Jun 30, 2020$18.06M+79254.1%
Q1 FY2020Mar 31, 2020$1.07M+36086.8%
Q4 FY2019Dec 31, 2019$55.76K+3793.9%
Q3 FY2019Sep 30, 2019$21.07K+117.3%
Q2 FY2019Jun 30, 2019$22.77K+134.8%
Q1 FY2019Mar 31, 2019$2.95K-69.6%
Q4 FY2018Dec 31, 2018$1.43K-44.9%
Q3 FY2018Sep 30, 2018$9.70K+273.2%
Q2 FY2018Jun 30, 2018$9.70K+348.1%
Q1 FY2018Mar 31, 2018$9.70K–
Q4 FY2017Dec 31, 2017$2.60K–
Q3 FY2017Sep 30, 2017$2.60K–
Q2 FY2017Jun 30, 2017$2.16K–

More Co-Diagnostics figures

See a number that looks wrong?